A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

NCT05687526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Telitacicept

Sponsor

RemeGen Co., Ltd.